Biote (BTMD) Cost of Revenue (2021 - 2026)

Biote's Cost of Revenue history runs 6 years deep, the most recent figure standing at $14.0 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 10.88% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $56.2 million (down 1.85% YoY), while the FY2025 annual figure was $54.9 million, down 5.63% from the prior year.
• Cost of Revenue was $14.0 million for Q1 2026 at Biote, down from $14.8 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $15.8 million in Q2 2023 to a low of $12.3 million in Q1 2022.
• Historically, Cost of Revenue has averaged $14.1 million across 5 years, with a median of $14.0 million in 2026.
• Biggest YoY gain for Cost of Revenue was 841.21% in 2022; the steepest drop was 66.17% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $15.4 million in 2022, then fell by 9.2% to $14.0 million in 2023, then grew by 0.24% to $14.0 million in 2024, then grew by 5.67% to $14.8 million in 2025, then dropped by 5.75% to $14.0 million in 2026.
• The last three Cost of Revenue figures came in at $14.0 million (Q1 2026), $14.8 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.